These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1864907)

  • 1. Rubella-specific IgG1 avidity: a comparison of methods.
    Thomas HI; Morgan-Capner P
    J Virol Methods; 1991; 31(2-3):219-28. PubMed ID: 1864907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The avidity of specific IgM detected in primary rubella and reinfection.
    Thomas HI; Morgan-Capner P
    Epidemiol Infect; 1990 Jun; 104(3):489-97. PubMed ID: 2347387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection.
    Thomas HI; Morgan-Capner P
    Epidemiol Infect; 1988 Dec; 101(3):591-8. PubMed ID: 3215288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of specific IgM and low avidity specific IgG1 following primary rubella.
    Thomas HI; Morgan-Capner P; Enders G; O'Shea S; Caldicott D; Best JM
    J Virol Methods; 1992 Sep; 39(1-2):149-55. PubMed ID: 1430059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology.
    Thomas HI; Morgan-Capner P; Cradock-Watson JE; Enders G; Best JM; O'Shea S
    J Med Virol; 1993 Nov; 41(3):196-200. PubMed ID: 8263500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
    Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
    J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus.
    Polanec J; Seppälä I; Rousseau S; Hedman K
    J Clin Lab Anal; 1994; 8(1):16-21. PubMed ID: 8164106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ELISA for the estimation of high-avidity and total specific IgG and IgM antibodies to rubella virus.
    Lehtonen OP; Meurman OH
    J Virol Methods; 1982 Sep; 5(1):1-10. PubMed ID: 7142359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection.
    Thomas HI; Morgan-Capner P; Roberts A; Hesketh L
    J Med Virol; 1992 Mar; 36(3):188-92. PubMed ID: 1314284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Simplified avidity assay of rubella IgG antibody in rubella virus infection].
    Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jun; 48(6):413-8. PubMed ID: 8752702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
    Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
    J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to primary rubella virus infection.
    Wilson KM; Di Camillo C; Doughty L; Dax EM
    Clin Vaccine Immunol; 2006 Mar; 13(3):380-6. PubMed ID: 16522781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of rubella IgG avidity over time after acute rubella infection.
    Böttiger B; Jensen IP
    Clin Diagn Virol; 1997 Aug; 8(2):105-11. PubMed ID: 9316732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of avidity of specific IgG for verification of recent primary rubella.
    Hedman K; Rousseau SA
    J Med Virol; 1989 Apr; 27(4):288-92. PubMed ID: 2723615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen.
    Thomas HI; Morgan-Capner P
    Epidemiol Infect; 1988 Dec; 101(3):599-604. PubMed ID: 3215289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
    Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
    J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection.
    Enders G; Knotek F
    Infection; 1989; 17(4):218-26. PubMed ID: 2767764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of low-avidity immunoglobulin G in oral fluid samples: new approach for rubella diagnosis and surveillance.
    Akingbade D; Cohen BJ; Brown DW
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):189-90. PubMed ID: 12522062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.
    Gutiérrez J; Rodríguez MJ; De Ory F; Piédrola G; Maroto MC
    J Clin Lab Anal; 1999; 13(1):1-4. PubMed ID: 10025730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.